• Bile Acid Metabolism Subtypes Mark Immune Dysfunction in CRC

  2026-06-16

  Feng et al. (2026) introduce a bile acid metabolism-driven molecular subtyping in colorectal cancer, identifying CLCA1, UGT2A3, and ZG16 as markers of immune dysfunction and prognosis. Their integrative approach links metabolic state to the tumor immune microenvironment, providing new insights for biomarker stratification and therapeutic prediction.

• Intravesical p21 mRNA-LNP Therapy: Advancing Bladder Cancer

  2026-06-15

  This article examines the development and validation of intravesically delivered p21 mRNA-loaded lipid nanoparticles as a tumor suppressor replacement strategy for bladder cancer. The study demonstrates robust tumor suppression, restored p21 expression, and minimal systemic toxicity, offering a clinically relevant approach for localized gene therapy.

• Tofacitinib citrate (CP-690550 citrate): Reliable JAK3 Inhib

  2026-06-15

  This article provides an evidence-based, scenario-driven guide for using Tofacitinib citrate (CP-690550 citrate, SKU A4135) in cell-based immune regulation and inflammatory disorder research. By addressing real-world laboratory challenges—from assay optimization to product selection—the piece demonstrates how SKU A4135 delivers reproducible, data-backed results for JAK-STAT pathway studies.

• Mechanistic Insights into Diuron-Induced Acute Renal Injury

  2026-06-14

  This study integrates network toxicology, transcriptomics, and experimental validation to clarify how Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) induces acute kidney injury via the JAK2/STAT1 pathway. The findings advance the mechanistic understanding of Diuron’s nephrotoxicity and provide a foundation for improved environmental health risk assessment.

• CARMIL MB Domain: Mechanisms of Actin Capping Protein Regula

  2026-06-13

  The reference study uncovers how the membrane-binding (MB) domain of CARMIL coordinates the targeting, activation, and release of actin capping protein (CP) at the cell membrane. These findings clarify longstanding questions about localized actin assembly and have practical implications for dissecting membrane-protein interactions in cytoskeletal research.

• 740 Y-P: Potent PI 3-Kinase Activator for PI3K/AKT Pathway S

  2026-06-12

  740 Y-P is a potent, cell-permeable PI 3-kinase activator used to modulate the PI3K/AKT signaling pathway in cellular and biochemical research. It enables precise investigation of vesicular trafficking, neuronal cell survival, and apoptosis mechanisms, with well-documented solubility and application parameters.

• HotStart Universal 2X Green qPCR Master Mix: Precision in Tu

  2026-06-12

  Explore how HotStart Universal 2X Green qPCR Master Mix empowers gene expression quantification in advanced cancer metastasis and stemness studies. This article uniquely bridges qPCR technology with the latest findings on tumor-derived extracellular vesicles.

• Erastin: Precision Ferroptosis Inducer for Cancer Biology Re

  2026-06-11

  Erastin enables targeted, reproducible induction of ferroptosis in RAS- or BRAF-mutant tumor models, supporting both mechanistic studies and translational research. This guide delivers workflow-validated protocols, troubleshooting strategies, and insights for leveraging Erastin in advanced oxidative stress and cancer cell death assays.

• ISR Inhibition Prevents Forgetting and Reverses Epileptic Me

  2026-06-11

  This study reveals that activation of the integrated stress response (ISR) underlies both natural and epilepsy-associated accelerated forgetting in mice. Pharmacological inhibition of the ISR with ISRIB (trans-isomer) preserves recognition memory, offering mechanistic insight and a potential new direction for neurocognitive disorder research.

• Luminescent ATP Detection Assay Kit: Advancing Mitochondrial

  2026-06-10

  Explore how the Luminescent ATP Detection Assay Kit enables precise, high-sensitivity ATP quantification in mitochondrial apoptosis studies. This article uniquely bridges advanced assay selection with mechanistic insight from current apoptosis research.

• A 83-01: Transforming TGF-β Pathway Research in Organoids

  2026-06-10

  A 83-01, a selective ALK-5 inhibitor, is redefining translational research by enabling precise modulation of the TGF-β/Smad pathway. This article delivers a mechanistic deep-dive alongside strategic recommendations for researchers leveraging organoid models, with special attention to recent advances in bovine liver organoid systems for metabolic disease modeling. Through evidence-based discussion and forward-looking guidance, we position A 83-01 as an indispensable tool for next-generation disease modeling, fibrosis, and EMT research.

• Efficient iPSC Differentiation into Retinal Ganglion Cells v

  2026-06-09

  The reference study introduces a chemically defined, reproducible protocol using dual SMAD and Wnt pathway inhibition to efficiently differentiate induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs) with over 80% purity. This method addresses prior limitations in variability and yield, providing a robust platform for glaucoma and neurodegenerative disease research.

• TMEM16F in Kupffer Cells Regulates Liver Defense Against Lis

  2026-06-09

  This study identifies TMEM16F expression in liver Kupffer cells as crucial for protecting against Listeria monocytogenes infection by maintaining plasma membrane integrity and controlling inflammation. The findings clarify cell-type specificity in host defense and offer new insight into metabolic and inflammatory regulation during bacterial challenge.

• ABT-737: A Potent BCL-2 Protein Inhibitor for Cancer Researc

  2026-06-08

  ABT-737 from APExBIO empowers researchers to dissect apoptosis in cancer models with high specificity, enabling robust and reproducible induction of cell death pathways. This article details optimized workflows, troubleshooting strategies, and new assay perspectives derived from recent breakthroughs on BCL-2 family inhibition.

• Sumatriptan Succinate: Mechanistic Insights & Translational

  2026-06-08

  This thought-leadership article unpacks the precise biological actions, experimental nuances, and translational opportunities for Sumatriptan Succinate. It integrates cutting-edge metabolic findings with strategic advice for researchers aiming to leverage this selective 5-HT1 receptor agonist, and provides actionable guidance for both established and emerging applications in migraine research and neuroinflammation modeling.

458 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page